Recall: Brimonidine
Mar. 2023Pharmacy Updates
Apotex Corp. is voluntarily recalling six lots of Brimonidine Tartrate Ophthalmic Solution, 0.15%. The drug is used to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. This recall is due to cracks that have developed in some of the Brimonidine tartrate ophthalmic solution bottles’ caps. Read the full text of the Brimonidine recall.
Recent Announcements
Medicaid Renewal
Starting in 2027, some Medicaid recipients (ages 19–-64) will have new requirements to keep their coverage.Aug. 2026Important Notices
Provider Directory Updates and Required Attestation
As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).Aug. 2026Important Notices
Voluntary nationwide recall: Tyenne (Fresenius – August 2026)
Fresenius Kabi is recalling one lot, lot 16UI07, of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL) 20 mL vials. Tyenne is used for the treatment of certain arthritis conditions.Aug. 2026Pharmacy Updates